Literature DB >> 11709357

Postantibiotic effects of antituberculosis agents alone and in combination.

C Y Chan1, C Au-Yeang, W W Yew, M Hui, A F Cheng.   

Abstract

The postantibiotic effects (PAEs) of seven antimycobacterial agents, tested at their respective peak concentrations in serum alone and in different combinations, against Mycobacterium tuberculosis ATCC 27294 were studied with a radiometric culture system in parallel with the viable count method. Rifampin gave the longest PAE (67.8 h) among the drugs used alone, and combinations of first-line drugs generally gave PAEs longer than 120 h. The data obtained might help provide a better understanding of the scientific basis of intermittently administered antituberculosis chemotherapy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11709357      PMCID: PMC90886          DOI: 10.1128/AAC.45.12.3631-3634.2001

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  22 in total

1.  Laboratory aspects of intermittent drug therapy.

Authors:  D A Mitchison; J M Dickinson
Journal:  Postgrad Med J       Date:  1971-11       Impact factor: 2.401

2.  In vitro and in vivo studies to assess the suitability of antituberculous drugs for use in intermittent chemotherapy regimens.

Authors:  J M Dickinson; D A Mitchison
Journal:  Tubercle       Date:  1968-03

3.  Suitability of isoniazid and ethambutol for intermittent administration in the treatment of tuberculosis.

Authors:  J M Dickinson; G A Ellard; D A Mitchison
Journal:  Tubercle       Date:  1968-12

4.  Postantibiotic suppression of bacterial growth.

Authors:  R W Bundtzen; A U Gerber; D L Cohn; W A Craig
Journal:  Rev Infect Dis       Date:  1981 Jan-Feb

Review 5.  Whither short-course chemotherapy?

Authors:  W Fox
Journal:  Br J Dis Chest       Date:  1981-10

6.  Suitability of rifampicin for intermittent administration in the treatment of tuberculosis.

Authors:  J M Dickinson; D A Mitchison
Journal:  Tubercle       Date:  1970-03

7.  Observations in vitro on the suitability of pyrazinamide for intermittent chemotherapy of tuberculosis.

Authors:  J M Dickinson; D A Mitchison
Journal:  Tubercle       Date:  1970-12

8.  Outcomes of patients with multidrug-resistant pulmonary tuberculosis treated with ofloxacin/levofloxacin-containing regimens.

Authors:  W W Yew; C K Chan; C H Chau; C M Tam; C C Leung; P C Wong; J Lee
Journal:  Chest       Date:  2000-03       Impact factor: 9.410

9.  Comparison of CO2 generation (BACTEC) and viable-count methods to determine the postantibiotic effect of antimycobacterial agents against Mycobacterium avium complex.

Authors:  G G Zhanel; M H Saunders; J N Wolfe; D J Hoban; J A Karlowsky; A M Kabani
Journal:  Antimicrob Agents Chemother       Date:  1998-01       Impact factor: 5.191

10.  Persistent effect of antibiotics on Staphylococcus aureus after exposure for limited periods of time.

Authors:  P J McDonald; W A Craig; C M Kunin
Journal:  J Infect Dis       Date:  1977-02       Impact factor: 5.226

View more
  10 in total

Review 1.  Pharmacokinetic and pharmacodynamic issues in the treatment of mycobacterial infections.

Authors:  E Nuermberger; J Grosset
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-03-13       Impact factor: 3.267

2.  Effectiveness of tuberculosis chemotherapy correlates with resistance to Mycobacterium tuberculosis infection in animal models.

Authors:  Zahoor Ahmad; Mostafa M Fraig; Michael L Pinn; Sandeep Tyagi; Eric L Nuermberger; Jacques H Grosset; Petros C Karakousis
Journal:  J Antimicrob Chemother       Date:  2011-05-20       Impact factor: 5.790

3.  Model-Based Exposure-Response Assessment for Spectinamide 1810 in a Mouse Model of Tuberculosis.

Authors:  Santosh Wagh; Chetan Rathi; Pradeep B Lukka; Keyur Parmar; Zaid Temrikar; Jiuyu Liu; Michael S Scherman; Richard E Lee; Gregory T Robertson; Anne J Lenaerts; Bernd Meibohm
Journal:  Antimicrob Agents Chemother       Date:  2021-08-23       Impact factor: 5.191

4.  Oxidative damage and delayed replication allow viable Mycobacterium tuberculosis to go undetected.

Authors:  Kohta Saito; Saurabh Mishra; Thulasi Warrier; Nico Cicchetti; Jianjie Mi; Elaina Weber; Xiuju Jiang; Julia Roberts; Alexandre Gouzy; Ellen Kaplan; Christopher D Brown; Ben Gold; Carl Nathan
Journal:  Sci Transl Med       Date:  2021-11-24       Impact factor: 19.319

5.  A microbiological assessment of novel nitrofuranylamides as anti-tuberculosis agents.

Authors:  Julian G Hurdle; Robin B Lee; Nageshwar R Budha; Elizabeth I Carson; Jianjun Qi; Michael S Scherman; Sang Hyun Cho; Michael R McNeil; Anne J Lenaerts; Scott G Franzblau; Bernd Meibohm; Richard E Lee
Journal:  J Antimicrob Chemother       Date:  2008-08-07       Impact factor: 5.790

6.  Concentration-dependent Mycobacterium tuberculosis killing and prevention of resistance by rifampin.

Authors:  Tawanda Gumbo; Arnold Louie; Mark R Deziel; Weiguo Liu; Linda M Parsons; Max Salfinger; George L Drusano
Journal:  Antimicrob Agents Chemother       Date:  2007-08-27       Impact factor: 5.191

7.  In vitro postantibiotic effects of rifapentine, isoniazid, and moxifloxacin against Mycobacterium tuberculosis.

Authors:  Chiu-Yeung Chan; Carrie Au-Yeang; Wing-Wai Yew; Chi-Chiu Leung; Augustine F B Cheng
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191

8.  Optimization of dosing regimens of isoniazid and rifampicin in children with tuberculosis in India.

Authors:  Blessed Winston Aruldhas; Richard M Hoglund; Jaya Ranjalkar; Joel Tarning; Sumith K Mathew; Valsan Philip Verghese; Anuradha Bose; Binu Susan Mathew
Journal:  Br J Clin Pharmacol       Date:  2019-01-17       Impact factor: 4.335

9.  Medical management of genitourinary tuberculosis.

Authors:  Tamilarasu Kadhiravan; Surendra K Sharma
Journal:  Indian J Urol       Date:  2008-07

10.  In Vitro Profiling of Antitubercular Compounds by Rapid, Efficient, and Nondestructive Assays Using Autoluminescent Mycobacterium tuberculosis.

Authors:  Gauri S Shetye; Kyung Bae Choi; Chang-Yub Kim; Scott G Franzblau; Sanghyun Cho
Journal:  Antimicrob Agents Chemother       Date:  2021-07-16       Impact factor: 5.191

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.